Dr. Bikash Medhi MBBS,MD(AIIMS),MAMS,FIMSA Professor, Department of Pharmacology, PGIMER, Chandigarh

Coordinator, PGIMER Pharmacovigilance Centre, Chandigarh. Ex-Secretary, Clinical Pharmacology of  Indian Pharmacology Society. Research Block B, 4th Floor, Room no 4043, Postgraduate Institute of Medical Education & Research, Chandigarh, 160012, India E-mail: drbikashus@yahoo.com drbikash11@rediffmail.com drbikashmedhi@gmail.com Mobile: +91-9914207510              +91-9815409652

Neurobehavioral Research Laboratory (NBRL) & Experimental Pharmacology Laboratory (EPL)

Our Team: The Neurobehavioral Research Laboratory (NBRL), Experimental Pharmacology Laboratory (EPL)  and Pharmacovigilance Center  is composed of a multi-disciplinary team of researchers. The following sections provide detailed information about each of the individual team members.

	Dr. Ajay Prakash (Senior Demonstrator) Ph.D., Panjab University, Chandigarh email: india.drajay@gmail.com Contact: +91-9781119969 Area of Research: Neuroscience, Clinical Pharmacology & Pharmacovigilance.
	Rakesh Kr Ruhela (PhD Student) M.Sc., Molecular Biology & Biotechnology (MBBT), Tezpur University, Assam email: ruhel82@gmail.com Contact: +91-9814564145 Area of Research: Autism, Cognitive Neuroscience & Epilepsy
	Baldeep Kumar (PhD Student) M.Pharmacy, Drug Discovery& Drug Development, Panjab University, Chandigarh. email: baldeep87@gmail.com Contact: +91-8194896278 Area of Research: Neurosciences, Epilepsy, Stroke, Pharmacokineticand Pharmacodynamic Studies.
	Harjeet Kaur (PhD Student) M.Sc., PharmaceuticalChemistry, Panjab University, Chandigarh. Email: harjeet108@yahoo.co.in Contact:  +91-9914527459 Area of Research: Neurosciences, Stroke, Epilepsy, Herbal Medicines, Nano Medicines.
	Shweta Sinha (PhD Student) M.Sc. Medical Biotechnology, Sardar Patel University, Gujarat Email-sinhashweta.27@gmail.com Contact: +91-8437503897      Area of Research: Drug Resistant and Cerebral Malaria and its Immunological basis, Antimalarials drug discovery.
	D.Hari Krishna Reddy (PhD Student) M.Pharma.,Pharmacology, Sri Venkateswara University, Tirupati (A.P) & Central Drug Research Institute (CDRI), Lucknow (U.P) email: harikrishnareddy0011@gmail.com Contact: +91-8725984535 Area of Research: Cerebral Stroke, Stem Cells and Neurodegenerative diseases
	Rahul Singh (PhD Student) M.Sc. PharmaceuticalChemistry, Punjabi University, Patiala email: rahulsingh0587@gmail.com Contact: +91-9988180587 Area of Research: Celiac disease-Preclinical study, Non-dietary approaches, Immunological aspects
	Harish Kumar (Ph.D. Scholar) M.Sc. Pharmacology, PGIMER,Chandigarh email: hkumar98@gmail.com Contact: +91-8901009946 Research Area. Ocular Pharmacology (Glaucoma), Neuropharmacology (Neurodegenerativedisease, Alzheimer’s disease), Gastro-intestinal pharmacology (IBD)
	Nitika Garg (PhD Student) M.Sc.Hons. School of Biochemistry, Panjab University (PU) email: nitikag26@gmail.com  Contact: +91-8427866210 Area of Research: Refractory epilepsy
	ShammyChandel (Ph.D Student) M.Sc.(Hons.) Microbiologyfrom H.P. University, SummerHill, Shimla Himachal Pradesh email: shammivimal777@gmail.com Contact: +91-9888769087 Area of Research:Epileptogenesis, Traumatic Brain Injury,Alzheimer’s disease, Neurodegenerative disease, IBD and Colon Cancer.
	Dr.Missamma M. (MD Student) MBBS from ASRAM MedicalCollege, Eluru email: missu.mulagala@gmail.com Contact: +91-7529878585 Area of Research:  Neurodegenerative Diseases
	Shringika Soni (JRF) M.Tech., Cognitive Neurosciences, Rajasthan University, Jaipur, Rajasthan. email: shringikasoni15@gmail.com Contact: +91-9592912925 Area of Research: Nano medicines, Stem cells & Autism.
	Ashutosh Singh (JRF) M.Sc. PharmaceuticalChemistry, Punjabi University, Patiala email- ashutoshsingh664@gmail.com Contact: +91-9653511424 Research Area: Alzheimer's and Dementia, Cerebral Malaria
	Dr. Phulen Sarma (DM Student) MBBS, MD email: phulen10@gmail.com Contact: +91-8728830834 Area of Research:  Neurosciences, Pharmacogenomics
	Eshani mahajan (M.Sc. Student) B.pharmacy (Panjab University) email :eshumahajanw@gmail.com Contact no.:-7508283825

	Dr. Pooja Sarotra  (Clinical Research Associate) Ph.D., Panjab University, Chandigarh email: poojasarotra@gmail.com Contact: +91-9815273784 Area of Research: cancer biology, Clinical Research
	Dr. Rakesh Sewal Ph.D., PGIMER, Chandigarh email: rakesh24sewal@gmail.com Contact:  Area of Research: Epilepsy

As part of the PGIMER, NBRL provides a preclinicaldiscovery platform for CNS target validation in preclinical in vivo and invitro models. Our well validated neurobehavioral assessment tools in CNSdisease models provide a unique platform for the screening and profiling ofexperimental therapeutics and genetic rodent models. We aim to accelerate theprogress in both fundamental and applied studies of nervous system function. Ouroverarching goal is to lead and enable translation of scientific discoveriesinto novel therapeutic approaches that improve the quality of life for patientswith disorders of the brain and spinal cord.  Our disease models focusincludes: cognition and memory, Autism Spectrum Disorder, Alzheimer’s disease, ALS,and Schizophrenia, as well as social interaction.

	Abhishek Misra (PhD Student) M.Pharmacy, NIPER, Guwahati email: pharmapgiabhishek@gmail.com Contact: +91-7508163275 Area of Research: Autism, Stem cells

Working of Pharmacovigilance

If there is any suspicion that an adverse event or adverse reaction has occurred, the healthcare professional attending to the patient, can fill up the suspected ADR former patient suspects that he has experienced an ADR can report  to the nearest ADR Monitoring Centers (AMCs) under Pharmacovigilance Programme of India (PvPI). There is a prescribed form that can be used in making reports to AMCs which can be downloaded from the website of IPC http://www.ipc.gov.in/PvPI/ADRReportingForm.pdf.  The details of IPC are given in the website of IPC i.e. http://www.ipc.gov.in/PvPI/pv_home.html.  The ADRs will be sent to WHO-Uppsala Monitoring Center (UMC) for analysis and signal detection. http://www.who-umc.org/DynPage.aspx?id=105196&mn1=7347&mn2=7489.  Simultaneously ADRs are evaluated at NCC and the inferences are used to recommend regulatory body i.e. CDSCO to take  necessary regulatory interventions, besides communicating risks to healthcare professionals and the public.

Regional Resource and Training& Technical Support Center for North India. (AMC-PGIMER)

PGIMER Chandigarh was identified as ADR Monitoring Centre (AMC) in July 2010. Dr. Bikash Medhi was appointed as Coordinator right from the first phase of Pharmacovigilance Program of India. PGIMER Chandigarh was later identified by National Coordinating Center as Regional Resource and Training& Technical Support Center for North India. Apart from the collection of ICSR’s; AMC has been actively involved in creating awareness amongst the health careprofessionals by means of organizing different CME’s throughout the Northern India.

Working of AMC-PGIMER

• Collection of ADR reports from hospital of PGIMER, Chandigarh.

• Reviewing  the ICSR^’s for seriousness and expectedness.

• Checking the completeness of reports for quality followed by causality assessment of ADR/AE cases, Follow up with the reporter for any incomplete information.

• Entry of ADR reports into Vigiflow (WHO’s database) by using inbuilt WHO-ART, ICD10, WHO drug dictionary.

• Delivering lecture on trending news and issues on drug safety, importance of reporting the ADR’s; for sensitization of healthcare professionals (Doctors, Nurses,Pharmacists).

• Preparing the monthly report of the ADR monitoring center.

• Documentation  and archival of the ADR reports in both soft and hard copies.

• Providing training to the personnel under pharmacovigilance program of India in north  India on “Vigiflow, reporting form, SOP’s”.

Pharmacovigilance Team:

	Mr. Vikas Kumar (Technical Associate) M. Pharm.(Pharmacology), Uttarakhand Technical University, Dehradun, Uttarakhand email: vikassainidli@gmail.com Contact: +91-987-637-2607 Area ofExpertise/Skills: Pharmacovigilance,VigiFlow, WHO-ART, ICD-10, ICSR processing, MedDRA, ICH Guidelines, MedicalCoding, Medical Writing, Epidemiology, Public Health, Pharmacogenomics,Pharmacogenetics.
	Dr. PrashantChandra Fuloria, (Technical Associate) Doctor OfPharmacy (PharmD), Sri Adi Chunchanagiri College of Pharmacy (Rajiv GandhiUniversity of Health Sciences) Bangalore, Karnataka email: dr.prashant_pharmd@rediffmail.com Contact:+91-7087494990 Area of Research: Adverse drug reaction reporting,Vigiflow processing, WHO ICD-10 coding,ICSR review and Causality assessmentetc.

1. Awarded Dr. D N Prasad memorial award with Goldmedal 2009 from Indian Council of Medical Research (ICMR), New Delhi.
2. Dr V K Bhargava Award with Gold medal  from National Academy of Medical Sciences 2013
3. Col. R N Chopra Oration 2014 by Indian Pharmacology Society(IPS)
4. Awarded Dr.B N. Ghosh Oration at 43^rd Annual Conference of IPS andInternational Conference on “Pharmacology & Translational Research” will beorganized by National Executive Committee in association with Food and DrugToxicology Research Centre, National Institute of Nutrition, Hyderabad from13th – 16th December, 2010.
5. Awarded International Fellowship from Alzheimer's Association International Organization(AAIC), July 18-22, 2015 at the Washington DC, USA  
6. Awarded International Fellowship from Alzheimer's Association International Organization(AAIC), July 13-18, 2013 at the Boston,USA. 
7. Awarded Bharat Joti Award 2013
8. Awarded Best 2^nd Prize for paperen titled: Effects of artemisinin, artemether, arteether on the pharmacokineticsof Phenytoin. In InternationalComprehensive Update on Diagnostic and Therapeutic in Epilepsy andNeuro-Electrophysiology Workshop (CUTE conference), New Delhi, Feb4&5,2006.
9. Member of Investigational New Drug ( INDcommittee, DCGI office, Ministry of Health, Nirman Bhawan, Government of India.
10. Secretary Clinical Pharmacology of  Indian Pharmacology Society
11. Selected as Core panel of expert for Task Forceto frame guidelines for submission of dossiers or proposals for regulation of biotechproducts (r-D~A product),Govtof India, Govt of India, Ministry of Health and Family Welfare, Nirman Bhawan,New Delhi, 2011
12. Core member of Expert committee CompensationGuideline Govt of India, Govt of India, Ministry of Health and Family Welfare,Nirman Bhawan, New Delhi, 2011
13. Elected as Fellow of International Medical SciencesAcademy(FIMSA) in 2006
14. Awarded Member of National Medical Academy (MAMS) 2009
15. Elected for National advisory board member in JKscience, Journal of Medical Education and research.
16. Elected for Editorial Board member, World Journal ofGastroenterology (2010-2012)
17. Elected as Editorial Board for  Journal of Neuroscience and Behavioral Health
18. Executive committee member of Society for Rational DrugUse, India
19. Travel grant from Department of Science and Technologyto attend IMSACON at Clare college in July 2002, Cambridge University, UK.
20. Travel grant from Department of Science and Technologyto attend IMSACON at Mayo Clinic  in 9-11^th  July 2002, Rochester, Minnesota, USA
21. Travel grant from Indian National Sciences Academy toattend International Challenges in Pediatric Pharmacology, Satellite Symposium(15^th World Congress of Pharmacology) Shanghai, China   June 28 – 30, 2006
22. Investigator award from International Epilepsy Society,Dublin, Ireland,   to attend EpilepsyCongress at Singapore, 7-12^th July 2007.
23. Travel award from CSIR 2008 to attend EpillesyCongress, Berlin, Germany
24. Travel award from DST 2008 to attend ExperimentalBiology, Washington DC,USA
25. Travel award from UGC 2008
26. Travel award from UGC 2009, to attend Experimental Biology,New Oreland,USA
27. Trained by DST  as GLP inspector 2010
28. Trained by USA-FDA  as GCP inspector 2008-2010
29. Executive committee member of Society forRational Drug Use, India
30. Executive committee member of Society forPharmacovigilance, India
31. Epilepsy award, Manila from ILAE March 2012.